1.10
-0.01 (-0.90%)
| Penutupan Terdahulu | 1.11 |
| Jumlah Dagangan | 23,074 |
| Harga / Pendapatan (P/E Ke hadapan) | 4.44 |
| Harga / Jualan (P/S) | 0.180 |
| Julat 52 Minggu |
| Margin Keuntungan | 10.55% |
| Margin Operasi (TTM) | 19.78% |
| EPS Cair (TTM) | 0.580 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 4.70% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -52.10% |
| Nisbah Semasa (MRQ) | 1.42 |
| Aliran Tunai Operasi (OCF TTM) | 44.34 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 54.17 M |
| Pulangan Atas Aset (ROA TTM) | 16.29% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Care Facilities (US) | Bercampur | Bercampur |
| Medical Care Facilities (Global) | Menaik | Bercampur | |
| Stok | Biote Corp. | Bercampur | Bercampur |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| BTMD | - | - | - | - |
| DCGO | - | - | - | 0.210 |
| PIII | - | - | - | - |
| AIRS | - | - | - | 0.540 |
| JYNT | - | - | - | 7.68 |
| NIVF | - | - | - | - |
AISkor Stockmoo
| Nilai 35% | 2.5 |
| AI Insight info | NA |
| Penilaian Relatif info | NA |
| Kesihatan Kewangan info | 2.5 |
| Masa 35% | 0.7 |
| AI Technical info | NA |
| Osilator Teknikal info | -0.5 |
| Purata Bergerak Teknikal info | 2.5 |
| Wang Pintar 30% | 0.0 |
| Konsensus Penganalisis info | 0.0 |
| Aktiviti Orang Dalam info | NA |
| Sentimen Berita info | NA |
| Persekitaran | ×0.91 |
| Persekitaran Makro info | -3.3 |
| Sektor berbanding Pasaran (6B) | +7.7% |
| Persetujuan Tonggak | ×1.25 |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | 2.2 |
| Skor Akhir | 1.27 |
|
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements. |
|
| Sektor | Healthcare |
| Industri | Medical Care Facilities |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 13.02% |
| % Dimiliki oleh Institusi | 65.98% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |